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Abstract
Background: Our objective was to compare the capacities of biofortified and standard colored beans to deliver
iron (Fe) for hemoglobin synthesis. Two isolines of large-seeded, red mottled Andean beans (Phaseolus vulgaris L.),
one standard ("Low Fe”) and the other biofortified ("High Fe”) in Fe (49 and 71 μg Fe/g, respectively) were used.
This commercial class of red mottled beans is the preferred varietal type for most of the Caribbean and Eastern
and Southern Africa where almost three quarters of a million hectares are grown. Therefore it is important to know
the affect of biofortification of these beans on diets that simulate human feeding studies.
Methods: Maize-based diets containing the beans were formulated to meet the nutrient requirements for broiler
except for Fe (Fe concentrations in the 2 diets were 42.9 ± 1.2 and 54.6 ± 0.9 mg/kg). One day old chicks (Gallus
gallus) were allocated to the experimental diets (n = 12). For 4 wk, hemoglobin, feed-consumption and body-
weights were measured.
Results: Hemoglobin maintenance efficiencies (HME) (means ± SEM) were different between groups on days 14
and 21 of the experiment (P < 0.05). Final total body hemoglobin Fe contents were different between the
standard (12.58 ± 1.0 mg {0.228 ± 0.01 μmol}) and high Fe (15.04 ± 0.65 mg {0.273 ± 0.01 μmol}) bean groups (P <
0.05). At the end of the experiment, tissue samples were collected from the intestinal duodenum and liver for
further analyses. Divalent-metal-transporter-1, duodenal-cytochrome-B, and ferroportin expressions were higher and
liver ferritin was lower (P < 0.05) in the standard group vs. the biofortified group. In-vitro analysis showed lower
iron bioavailability in cells exposed to standard ("Low Fe”) bean based diet.
Conclusions: We conclude that the in-vivo results support the in-vitro observations; biofortified colored beans
contain more bioavailable-iron than standard colored beans. In addition, biofortified beans seems to be a
promising vehicle for increasing intakes of bioavailable Fe in human populations that consume these beans as a
dietary staple. This justifies further work on the large-seeded Andean beans which are the staple of a large-region
of Africa where iron-deficiency anemia is a primary cause of infant death and poor health status.
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Iron (Fe) deficiency is the most common nutrient defi-
ciency worldwide [1]. A major cause of Fe deficiency is
low bioavailability from plant-based diets containing
mineral absorption inhibitors such as polyphenols. Policies
aimed to decrease Fe deficiency occurrence comprise
primarily in the use of dietary iron additives for at-risk
populations, food fortification, and diversification of diets.
However, these strategies have met with limited success in
resource mostly in poor countries because of cost, limited
access to health care, partial availability of centralized food
processing facilities required for post-harvest crop fortifi-
cation, and other factors [2-4]. Biofortification, or the crop
improvement and breeding of iron-rich staples, is an
attractive alternative to fortification or diversification of
the diet, since delivery of the iron-rich staple is achieved
through variety release and seed promotion.
The common bean (Phaseolus vulgaris L), provides sig-
nificant quantities of protein and energy and is a source of
vitamins and minerals including Fe [5]. The common bean
is an attractive candidate for Fe biofortification because
there is genetic variability of Fe concentration and there-
fore it is possible to breed for significant increases in Fe
concentrations in beans [6]. Also, Fe concentrations in
beans are high relative to the cereals and therefore beans
can deliver substantial increased amounts of Fe. Bean gen-
otypes with high Fe concentrations delivered more
absorbed Fe to rats than genotypes with lower concentra-
tions of Fe [6].
Recently, breeding at CIAT (Centro Internacional de
Agricultural Tropical, Cali, Columbia) has developed bio-
fortified beans that contain up to 100 μg Fe/g bean, a sub-
stantial increase over standard beans [7,8]. However, an
increase in Fe concentration in beans or other staple food
crops may not necessarily translate into a proportional
increase in absorbed Fe because genotypes with high Fe
concentrations may also have increased (or decreased)
concentrations of Fe absorption inhibitors or enhancers.
Therefore, it is necessary to measure the amount of bioa-
vailable Fe as well as the concentration of Fe in these new
iron-enhanced crops.
A previous study aimed to compare the capacities of bio-
fortified and standard small-seeded black beans to deliver
Fe for hemoglobin synthesis in Fe deficient pigs, indicated
that the pigs receiving the high-Fe bean diet gained signifi-
cantly more hemoglobin Fe than the piglets on the diet
containing standard beans. This result demonstrates that
Fe biofortified beans can enhance Fe status in Fe- deficient
pigs even when fed as part of a complete diet where the
difference in Fe concentration between the diets was only
12 μg/g and the feeding period was only 5 weeks [7]. Simi-
lar results using in vivo and in vitro systems would also be
pertinent analytical tools for testing biofortified varieties
and the results of Caco-2 cell testing has already been
applied to a set of common bean varieties showing signifi-
cant differences in bioavailability [9]. The objective of this
study was to compare the capacities of biofortified and
standard, large-seeded, red- mottled bean lines to deliver
Fe for hemoglobin synthesis and to improve the Fe status
of Fe deficient broiler chickens. In addition, we aimed to
determine if the in vitro observations of bean Fe bioavail-
ability would be evident in an in vivo long term feeding
trial.
Materials and methods
Animals, Diets and Study Design
Thirty six Cornish cross fertile broiler eggs were
obtained from a commercial hatchery (Moyer’sc h i c k s ,
Quakertown, PA). The eggs were incubated under opti-
mal conditions at the Cornell University Animal Science
poultry farm incubator. Upon hatching (hatchability rate
was 92%), chicks were allocated into 2 treatment groups
on the basis of body weight, gender and blood hemoglo-
bin concentration (aimed to ensure equal distribution
between groups, n = 12): 1. “High-Fe": 60% red-mottled
bean diet (54ppm Fe); 2. “Low-Fe": 60% red-mottled
bean diet (42ppm Fe). Experimental diets had no sup-
plemental Fe. Diets composition are shown in Table 1.
Chicks were housed in a total-confinement building (1
chick per 0.5 m
2 metal cage). Birds were under indoor
Table 1 Composition of experimental diets
Ingredient Low-Fe Bean
Diet
High-Fe Bean
Diet
g/kg (by formulation)
High-Fe Beans (71 μg Fe/g) _ 600
Low-Fe Beans (49 μg Fe/g) 600 _
Corn 200 200
Corn oil 30 30
Dry skim milk 100 100
Vitamin/mineral premix (no Fe)
1 70 70
DL-Methionine 2.5 2.5
Choline Chloride 0.75 0.75
Total (g) 1000 1000
Concentrations of selected
components
mean ± SEM, n = 5 (by analysis)
4
Fe (μg Fe/g)
2 42.9 ± 1.2
a 54.6 ± 0.9
b
Total Phenols (gallic acid, μg/g)
3 103.5 ± 5.5
a 101.8 ± 6.1
a
Phytate:Fe molar ratio
3 8.28 ± 9.2
a 8.59 ± 1.06
a
1Vitamin and mineral premix provided/kg diet (330002 Chick vitamin mixture;
230000 Salt mix for chick diet; Dyets Inc. Bethlehem, PA).
2Iron concentrations in the diets were determined by an inductively-coupled
argon-plasma/atomic emission spectrophotometer (ICAP 61E Thermal Jarrell
Ash Trace Analyzer, Jarrell Ash Co. Franklin, MA) following wet ashing.
3Method for determining phenol concentrations and phytate contents are
described in the materials and methods section.
4Within a row, means without a common letter are significantly different,
P < 0.05.
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Each cage was equipped with an automatic nipple drin-
ker and manual self feeder. All birds were given ad libi-
tum access to water (Fe content was 0.379 ± 0.012ppm).
Feed intakes were measured daily (as from day 1). Iron
intakes were calculated from feed intakes and Fe con-
centration in the diets.
The two red-mottled bean lines used in the study
were developed from a commercial variety for Africa
(CAL96, Low-Fe that has been released in Uganda and
widely used in crosses by CIAT, ECABREN and
SABRN) and an introgressed line (NUA35, High-Fe)
from the backcross CAL96 × (CAL96 × G14519) as
described in [8]. Seed was multiplied in Darien, Colom-
bia under phosphorus fertilized, standard agronomic
conditions and shipped to Ithaca, New York in sealed
containers imported as grain.
Blood Analysis and Hemoglobin (Hb) Measurements
Blood samples were collected weekly from the wing vein
(n = 12, ~100 μL) using micro-hematocrit heparinized
capillary tubes (Fisher, Pittsburgh, PA). Samples were
collected in the morning following an 8 h overnight fast.
The samples were analyzed for hemoglobin (Hb) con-
centration (see below). Body weights and hemoglobin
concentrations were measured weekly.
Fe bioavailability was calculated as hemoglobin main-
tenance efficiency (HME) [7,10-14]:
HME =
Hb Fe, mg (ﬁnal) − Hb Fe, mg (initial)
Total Fe Intake, mg
× 100
Where Hb-Fe (index of Fe absorption) = total body
hemoglobin Fe. Hb-Fe was calculated from hemoglobin
concentrations and estimates of blood volume based on
body weight (a blood volume of 85 mL per kg body
weight is assumed) [12-14]:
Hb − Fe

mg

=B . W .

kg

× 0.085 L blood/kg × Hb

g/L

× 3.35mg Fe/g Hb.
Fe intakes were calculated from feed intake data and
Fe concentrations in the feed.
A tt h ee n do ft h ee x p e r i m e n t( d a y2 8 ) ,b i r d sw e r e
euthanized by carbon dioxide exposure. The digestive
tracts and livers were quickly removed from the carcass
and separated into various sections for tissue (small
intestine and liver ~ 1-2 cm; ~2-3gr, respectively). The
samples were immediately frozen in liquid nitrogen, and
then stored in a -80°C freezer until analysis.
All animal protocols were approved by the Cornell
University Institutional Animal Care and Use
Committee.
Blood Hb concentrations were determined spectro-
photometrically using the cyanmethemoglobin method
(H7506-STD, Pointe Scientific Inc. Canton, MI) follow-
ing the kit manufacturer’s instructions.
Isolation of Total RNA
Total RNA was extracted from 30 mg of the duodenal tis-
sue (tissue was harvested from the proximal duodenum, n
= 6) using Qiagen RNeasy Mini Kit (RNeasy Mini Kit, Qia-
gen Inc., Valencia, CA)
1 according to the manufacturer’s
protocol. Briefly, tissues were disrupted and homogenized
with a rotor-stator homogenizer in buffer RLT
®, contain-
ing b-mercaptoethanol. The tissue lysate was centrifuged
for 3 minutes at 8,000 g in a micro centrifuge. An aliquot
of the supernatant was transferred to another tube, com-
bined with 1 volume of 70% ethanol and mixed immedi-
ately. Each sample (700 μL) was applied to an RNeasy
mini column, centrifuged for 15 s at 8000 g, and the flow
through material was discarded. Next, the RN easy col-
umns were transferred to new 2-mL collection tubes, and
500 μL of buffer RPE
® was pipetted onto the RNeasy col-
umn followed by centrifugation for 15 s at 8000 g. An
additional 500 μL of buffer RPE were pipetted onto the
RNeasy column and centrifuged for 2 min at 8000 g.
Total RNA was eluted in 50 μLo fR N a s ef r e ew a t e r .
All steps were carried out under RNase free conditions.
RNA was quantified by absorbance at A 260/280. Integrity
of the 28S and 18S ribosomal RNAs was verified by
1.5% agarose gel electrophoresis followed by ethidium
bromide staining. DNA contamination was removed
using TURBO DNase treatment and removal kit from
AMBION (Austin, TX, USA).
DMT1, DcytB and Ferroprtin Gene Expression Analysis
As previously described [12,14,15], briefly, PCR was car-
ried out with primers chosen from the fragment of the
chicken (Gallus gallus) duodenal DMT1 gene (GeneBank
database; GI 206597489) (forward: 5’-AGC CGT TCA
CCA CTT ATT TCG-3’; reverse: 5’-GGT CCA AAT
AGG CGA TGC TC-3’), DcytB gene (GI 20380692) (for-
ward: 5’-GGC CGT GTT TGA GAA CCA CAA TGT T-
3’;r e v e r s e :5 ’-CGT TTG CAA TCA CGT TTC CAA AGA
T-3’) and Ferroportin gene (GI 61098365) (forward: 5’-
GAT GCA TTC TGA ACA ACC AAG GA’;r e v e r s e :5 ’-
GGA GAC TGG GTG GAC AAG AAC TC-3’). Riboso-
mal 18S was used to normalize the results (GI 7262899)
(forward: 5’- CGA TGC TCT TAA CTG AGT-3’; reverse:
5’-CAG CTT TGC AAC CAT ACT C-3’).
Determination of the linear phase of the PCR amplifi-
cation was performed (Access RT-PCR system, Promega,
Madison, WI) with pooled aliquots removed at 15, 20,
25, 30, 35, 40, 45, 50, and 55 cycles. Amplification of
the chicken duodenal DMT1, DcytB and Ferroportin
genes were performed for 32, 40 and 30 cycles respec-
tively, which consisted of denaturation (95°C, 30 s),
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ribosomal 18S was amplified at 32 cycles under identical
conditions in a different tube. All PCR products were
separated by electrophoresis on 2% agarose gel, stained
with ethidium bromide, and quantified using the Quan-
tity One 1-D analysis software (Bio-Rad, Hercules, CA).
In-vitro Iron Bioavailability Assessment
An in vitro digestion/Caco-2 cell culture model [16] was
used to assess in vitro iron bioavailability. With this
method, the cooked bean samples of the two diets were
subjected to simulated gastric and intestinal digestion.
Briefly, the intestinal digestion is carried out in cylindrical
inserts closed on the bottom by a semipermeable mem-
brane and placed in wells containing Caco-2 cell mono-
layers bathed in culture medium. The upper chamber was
formed by fitting the bottom of Transwell insert ring
(Corning) with a 15000 Da molecular weight cut off
(MWCO) membrane (Spectra/Por 2.1, Spectrum Medical,
Gardena, CA). The dialysis membrane was held in place
using a silicone ring (Web Seal, Rochester, NY).
Iron uptake by the cell monolayers was assessed by mea-
suring ferritin concentrations in the cells. Six replicates of
each Fe bioavailability measurement were performed. In
terms of materials for the study, Caco-2 cells were
obtained from the American Type Culture Collection
(Rockville, MD) at passage 17 and used in experiments at
passage 29. Cells were seeded at densities of 50,000 cells/
cm
2 in collagen-treated 6 well plates (Costar Corp., Cam-
bridge, MA). The integrity of the monolayer was verified
by optical microscopy. The cells were cultured at 37°C in
an incubator with 5% CO2 and 95% air atmosphere at con-
stant humidity, and the medium was changed every 48 h.
The cells were maintained in Dulbecco’sm o d i f i e d
Eagle medium plus 1% antibiotic/antimycotic solution,
25 mmol/L HEPES, and 10% fetal bovine serum. 48 h
prior the experiment, the growth medium was removed
from culture wells, the cell layer was washed, and the
growth medium was replaced with minimum essential
media (MEM) at pH 7.0. The MEM was supplemented
with 10 mmol/L PIPES, 1% antibiotic/antimycotic solu-
tion, 4 mg/L hydrocortisone, 5 mg/L insulin, 5 μg/L sele-
nium, 34 μg/L triiodothyronine, and 20 μg/L epidermal
growth factor. This enriched MEM contained less than
80 μg Fe/L.
All ingredients and supplements for cell culture media
were obtained from Gibco (Rockville, MD). The cells
were used in the Fe uptake experiment at 13 days post
seeding. In these conditions, the amount of cell protein
measured in each well was highly consistent between
wells. In experiment day, 1.5 mL of the digested sample
was added to the insert’s upper chamber and incubated
for 2h. Then, inserts were removed and 1 mL of MEM
was added. Cell cultures were incubated for 22h at 37°C.
It was previously shown that intracellular ascorbic acid
status might influence ferritin formation (i.e. cellular Fe
uptake), and Fe related transporters and enzyme expres-
sion in Caco-2 cells [17,18]. In the current study, sam-
ples were not added with ascorbic acid when Fe
bioavailability was tested in vitro.
Harvesting of Caco-2 Cells for Ferritin Analysis
The protocols used in the ferritin and total protein con-
tents analyses of Caco-2 cells were similar to those pre-
viously described [14,19]. Briefly, growth medium was first
removed from the culture well by aspiration and the cells
were washed twice with a solution containing 140 mmol/L
NaCl, 5 mmol/L KCl, and 10 mmol/L PIPES at pH 7.0.
The cells were harvested by adding an aliquot of deionized
water and placing them in a sonicator (Lab-Line instru-
ments, Melrose Park, IL).
The ferritin and total protein concentrations were
determined on an aliquot of the harvested cell suspen-
sion with a one-stage sandwich immunoradiometric
assay (FER-IRON II Ferritin assay, Ramco laboratories,
Houston, TX) and a colorimetric assay (Bio-Rad DC
Protein assay, Bio-Rad, Hercules, CA), respectively.
Caco-2 cells synthesize ferritin in response to increases
in intracellular iron concentration. Therefore, we used
the ratio of ferritin/total protein (expressed as ng ferri-
tin/mg protein) as an index of the cellular Fe uptake.
All glassware used in the sample preparation and ana-
lyses was acid washed.
Ferritin and Fe in the Liver
Liver samples were treated as described by Mete et al.
[20]. Briefly, 1 g of sample was diluted into 1 mL of 50
mM Hepes buffer, pH 7.4, and homogenized on ice at
5000 g and for 2 min. One mL of each homogenate was
subjected to heat treatment for 10min at 75°C to aid
isolation of ferritin since other proteins are not stable at
that temperature [14,15,20,21]. After heat treatment the
samples were immediately cooled down on ice for
30min. Thereafter, samples were centrifuged at 13000 g
for 30min at 4°C until a clear supernatant was obtained
and the pellet containing most of the insoluble denatu-
rated proteins was discarded. All tests were conducted
in duplicates for each animal (n = 6).
Electrophoresis, Staining and Measurement of Gels
Native polyacrylamide gel electrophoresis was conducted
using a 6% separating gel and a 5% stacking gel. Samples
were run at a constant voltage of 100 V. After electro-
phoresis, the gels were treated with either of the two
stains: Coomasie blue G-250 stain, specific for proteins,
or potassium ferricyanide (K3Fe(CN)6) stain, specific for
iron. The corresponding band found in the protein and
iron stained gel was considered to be ferritin [20,21].
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surements of the bands were conducted using the Quan-
tity-One 1-D analysis program (Bio-Rad, Hercules, CA).
The local background was subtracted from each sample.
Horse spleen ferritin (Sigma Aldrich Co., St. Louis, MO)
was used as a standard for calibrating ferritin protein and
iron concentrations of the samples. Dilutions of the horse
spleen ferritin were made and treated similarly to the liver
supernatant samples in order to create a reference line for
both protein and iron-stained gels. Iron levels were deter-
mined using the same calibration since approximately 20%
of the weight of horse spleen ferritin is iron [21,22].
Saturation levels of ferritin with iron were calculated as
the percentage of the iron present in the protein to the
maximum amount of iron atoms (4500 iron atoms/ferritin
molecule) ferritin can incorporate [14,15,20].
Polyphenol Concentrations in Diets
Samples (n = 5, 1.5 g) of the diets were extracted with 4
mL of acidified methanol (methanol and 1.0 M HCl,
85:15 v/v). The samples were shaken for 2h, vortexed to
mix, and centrifuged at 12800 g for 10 min to remove
insoluble material.
To evaluate the total phenols content in the extracts, we
used the following method [10,14,22]; Briefly, to 0.125 mL
of the supernatant, 0.5 mL of deionized water and 0.125
mL of the Folin-Ciocalteau reagent were added. The mix-
ture was left at room temperature for 5min, and then,
0.125 mL of aqueous Na2CO3 (7% wt/vol) was added. The
final volume of the mixture was adjusted to 3 mL with
deionized water and was left at room temperature for
1.5h. The absorbance was measured at 760 nm against a
reagent blank. The amount of total phenolics was
expressed as gallic acid equivalents (μg/g of sample).
Phytate Content in Diets
A Dionex liquid (Dionex Corp. Sunnyvale, CA) chroma-
tograph system (AS50 autosampler), equipped with con-
ductivity detector model ED50, and gradient pump GS50
were used along with an IonPac AG11 guard column and
IonPac AS11 column (4 × 250 mm) to quantify phytate.
PeakNet 6.40 software was used to process chromato-
graphic data. The mobile phases were (A) 200 mmol/L
NaOH (carbonate-free) and (B) deionized water, using a
flow rate of 1 mL/min. Phytate was extracted from 250
mg of dry, lyophilized diet sample, in 10 mL of a 1.25%
H2SO4 solution; the extraction process was 2h, after
which the samples were centrifuged at 3660g for 10 min.
Subsamples were diluted 1:10 with deionized water, and
10μL was injected and analyzed (n = 5).
Statistical Analysis
Results were analyzed by ANOVA using the general lin-
ear models procedure of SAS software (SAS Institute
Inc. Cary, NC). Differences between treatments were
compared by Tukey’s test and values were considered
statistically different at P < 0.050 (values in the text are
means ± SEM).
Results
Growth rates, hemoglobin (Hb), Hb Fe and Hb
maintenance efficiency (HME)
There were no significant differences in feed intakes at
any time throughout the study; however, Fe intakes
were consistently higher in the “High-Fe” group vs.
“Low-Fe” group (Table 2). Hemoglobin concentrations
were higher (P > 0.05) in the “High-Fe” group vs. “Low-
Fe” group. Significant differences were measured in
HME on days 14 and 21 of the experiment between the
“High-Fe” group vs. “Low-Fe” treatment (Table 2).
In addition, the increase in total body Hb Fe from the
beginning of the study to the end of the 4th week was
significantly greater in the “High-Fe” group vs. “Low-Fe”
group (12.6 ± 0.7 mg and 10.2 ± 0.4 mg, respectively,
P < 0.05, Table 2).
Gene expression of iron transporters (DMT-1, Ferroportin)
and DcytB in the duodenum
Gene expression analysis of duodenal DMT-1, Ferropor-
tin and DcytB, with results reported relative to 18S
rRNA, revealed increased mRNA expression of DMT1,
DcytB and Ferroportin in the “Low-Fe” group compared
to “High Fe” group (Figure 1) (n = 6, P > 0.05).
Caco-2 cell ferritin protein formation
An in vitro digestion/Caco-2 cell culture model was used
to evaluate Fe bioavailability from the test diets by measur-
ing ferritin formation in the cells (ie. a measure of cell Fe
uptake) following exposure to digests of the samples. Fer-
ritin concentrations were significantly higher (P < 0.05) in
cells exposed to the “High Fe” group vs. “Low Fe” group
(n = 6, Table 3).
Ferritin and iron in the liver
The avian ferritins corresponded to a weight of approxi-
mately 470 to 500 kDa [14,15,20-22]. No significant differ-
ences in liver Fe or liver ferritin concentrations were
measured between the treatment groups (n = 6, P > 0.05).
The mean values of ferritin protein and the amount of
iron present in the ferritin of the liver samples of all ani-
mals are presented in Table 4.
Total phenolic concentration in the diet sample
The total phenolics in the bean-based diet samples are
expressed as gallic acid equivalents (μg/g of sample, mean
± STD, n = 5) and were as follows: 103.5 ± 5.5 μg/g diet
and 101.8 ± 6.1 μg/g diet in the “ Low Fe”, and “High Fe”,
respectively (P < 0.05) as shown in Table 1.
Tako et al. Nutrition Journal 2011, 10:113
http://www.nutritionj.com/content/10/1/113
Page 5 of 10Phytate concentration in the diet samples
No significant differences in phytate concentration were
measured between treatments diets (n = 5; P > 0.05). Diet-
ary phytate concentrations (IP6) are shown in Table 1.
Discussion
The main objective of the present study was to compare
the capacities of biofortified ("High Fe”)a n ds t a n d a r d
("Low Fe”) large-seeded, red-mottled beans that differ in
Fe concentration (71 μg/g vs. 49 μg/g, respectively) to
deliver Fe for Hb synthesis and to improve the Fe status
of Fe-deficient broiler (Gallus gallus) chickens. These
beans are an important commercial class for human
consumption in Eastern and Southern Africa. In addi-
t i o n ,t h e ya r eg r o w ni nt h eC a r i b b e a na n dt h eA n d e a n
region of South America where they originated as a spe-
cific group of common bean [8].
Our data showed that Fe deficient birds receiving the
high Fe bean diet gained significantly more Hb Fe than
the birds on the diet containing standard beans. This
result clearly shows that Fe biofortified red-mottled
beans can enhance Fe status in Fe-deficient birds even
when fed as part of a complete diet, where the difference
in Fe concentration between the diets was only 12 μg/g
and the feeding period was only 4 weeks.
In addition, it was previously shown that colored
beans are rich with polyphenols that may decrease Fe
bioavailability both in vitro [9] or in vivo [14]. According
to the present study, it appears that it is possible to
counteract the Fe absorption inhibitory effect of poly-
phenols by increasing Fe concentration in beans. This
knowledge is vital for developing plant breeding strate-
gies as part of the continuing battle with dietary Fe defi-
ciency anemia.
Furthermore, the results obtained in the present study
are consistent with a previous study where we have
demonstrated that Fe biofortified black beans delivered
more bioavailable Fe than standard black beans to Fe
Table 2 Body weights, Fe intakes, hemoglobin maintenance efficiency (HME), and total body Hb Fe content in chicken
fed the tested diets from d 0 to d 56
1
Treat
* Day 0 Day 7 Day 14 Day 21 Day 28
Body weight (g)
High Fe 42.5
a ± 2.1 107.6
a ± 3.9 214.6
a ± 5.8 427.8
a ± 16.8 684.3
a ± 21.9
Low Fe 42.9
a ± 2.6 103.9
a ± 4.3 204.1
a ± 9.1 398.7
a ± 18.8 599.9
b ± 26.1
Feed intake (kg/d)
2
High Fe - 0.02
a ± 0.005 0.07
a ± 0.008 0.07
a ± 0.01 0.08
a ± 0.01
Low Fe - 0.02
a ± 0.006 0.06
a ± 0.007 0.07
a ± 0.009 0.08
a ± 0.01
Fe intake (mg)
3
High Fe - 9.6
a ± 0.7 33.8
a ± 1.5 58.7
a ± 4.9 87.6
a ± 6.5
Low Fe - 7.0
b ± 0.5 23.3
b ± 1.8 44.4
b ± 3.8 65.6
b ± 4.9
Hemoglobin (g/L)
High Fe 90.50
a ± 8.3 85.85
a ± 4.0 79.60
a ± 4.5 80.14
a ± 6.5 75.50
a ± 3.1
Low Fe 90.70
a ± 8.7 78.40
a ± 4.7 76.10
a ± 3.7 78.40
a ± 2.3 73.71
a ± 2.3
Total body Hb Fe content (mg)
4
High Fe 1.08
a ± 0.06 2.62
a ± 0.18 4.83
a ± 0.31 9.77
a ± 0.58 15.04
a ± 0.65
Low Fe 1.11
a ± 0.08 2.36
a ± 0.24 4.58
a ± 0.29 8.50
b ± 0.35 12.58
b ± 1.03
Hemoglobin maintenance efficiency (HME, %)
5
High Fe - 16.0
a ± 1.9 11.0
a ± 0.9 14.7
a ± 1.0 15.9
a ± 0.7
Low Fe - 18.5
a ± 3.8 15.1
b ± 1.2 16.7
b ± 0.7 17.6
a ± 1.3
a, b Within a column, means without a common letter are significantly different, P < 0.05.
1Values are means ± SEM, n = 12.
2Values are mean daily feed intakes for the 7 days proceeding the day designated in the column heading.
3Values are mean ± SEM (cumulative weekly from day 0)
4,5Fe bioavailability was calculated as hemoglobin maintenance efficiency (HME) (7,10-14):
HME =
Hb Fe, mg (ﬁnal) − Hb Fe, mg (initial)
Total Fe Intake, mg
× 100
Where Hb-Fe = total body hemoglobin Fe. Hb Fe was calculated from hemoglobin concentrations and estimates of blood volume based on body weight (a
blood volume of 85 mL per kg body weight is assumed) (10,11,14,23):
Hb − Fe

mg

=B . W .

kg

× 0.085 L blood/kg × Hb

g/L

× 3.35mg Fe/g Hb.
* The experimental diets: 1. “High Fe": 60% colored bean diet (54ppm Fe); 2. “Low Fe": 60% colored bean diet (42ppm Fe).
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Page 6 of 10deficient piglets and improved their Fe status by increas-
ing the piglets total body Hb Fe content. Similar to the
current study, the difference in Fe concentration
between the two diets (standard vs. biofortified black
beans) was 12 μg/g, however, the duration of the study
was 5 weeks [7]. Importantly, the previous work was
performed with small-seeded beans which have a higher
ratio of seed coat to total seed weight than the large-
seeded beans used in this study which may affect
bioavailability due to a greater percentage of polyphe-
nols per seed weight [9].
In a different study, Schaffer et al. [23] compared the
effects of high Fe (13.4 μg/g) and low Fe (2.2 μg/g) rice on
Fe status indices in weaned pig l e t s .A tt h ee n do ft h e3 3
days feeding trial, none of the indices differed. A possible
explanation for the lack of effect in this study is that both
diets were extremely deficient in Fe; Hb concentrations at
the end of the study were only 45 g/L. In contrast, in a
study conducted by Haas et al. [24] Fe-biofortified rice
improved Fe stores in Fe-deficient but not anemic Filipino
women in a nine months efficacy trial, even though Fe
concentrations in the polished rice they used were extre-
mely low (3.2 μg/g for the high Fe rice and 0.57 μg/g for
the control rice).
The longer feeding duration in the Haas study [24]
and lower Fe requirements in adult women compared
with early weaned pigs may explain why they found an
effect whereas Schaffer et al. [23] did not.
In the current study and in order to demonstrate a pos-
sible nutritional benefit of the biofortified red-mottled
beans (i.e. improving Fe status), we first tested the Fe bioa-
vailability by measuring cellular ferritin concentrations in
Caco-2 cells exposed to the red-mottled beans and high
vs. low bean-based diets. This in-vitro method has been
used to screen food crops as part of the plant breeding
strategy aimed to alleviate micronutrient deficiencies in
Figure 1 Chicken duodenal mRNA expression of divalent metal transporter 1 (DMT1), ferroportin, and duodenal cytochrome B (DcytB)
in birds given “High Fe bean” diet (54.6 ppm Fe) and “Low Fe bean” diet (42.9 ppm Fe). Changes in mRNA expression are shown relative
to expression of 18S rRNA in arbitrary units (AU). Values are means ± SEM, n = 6, P < 0.05.
Table 3 Ferritin concentrations in Caco 2 cells exposed to
samples of beans only (whole bean, 49 ppm Fe and 71
ppm Fe, “Low Fe” and “High Fe” beans, respectively) and
bean-based diets digests; “Low Fe” bean diet (42 ppm
Fe) and “High Fe” bean diet (54 ppm Fe)
Tested sample
1 Ferritin (ng/mg of protein)
“Low Fe” bean only 7.82 ± 0.75
d
“High Fe” bean only 30.6 ± 2.08
a
“Low Fe” bean-based diet 11.2 ± 0.97
c
“High Fe” bean-based diet 15.7 ± 1.05
b
Baseline
2 4.06 ± 0.37
e
1Caco 2 bioassay procedures and preparation of the digested samples are
described in the materials and methods sections.
2Cells were exposed to only MEM growth media without added food digests
and Fe. Values are means ± SEM, n = 6. Means with no letters in common are
significantly different, P < 0.05.
Tako et al. Nutrition Journal 2011, 10:113
http://www.nutritionj.com/content/10/1/113
Page 7 of 10relevant populations [7,9-12,14,16,19]. Based on the in-
vitro observations showing higher ferritin concentrations
in cells exposed to the high Fe bean and high Fe bean
b a s e dd i e t( T a b l e3 ) ,w ed e s i g n e da nin-vivo study aimed
to determine if the in-vitro observations of bean Fe bioa-
vailability would be evident in an in-vivo feeding trial.
We selected the broiler chicken as a model for Fe bioa-
vailability studies since the modern broiler chicken is a
fast growing animal that is sensitive to dietary deficien-
cies of trace minerals such as Fe [12-15]. As such, it
holds potential as a relevant model as a source of tissues
for in-vitro Fe bioavailability studies, in-vivo feeding
trials, or both. In addition, the use of broiler chickens for
in-vivo studies represents a significant cost savings com-
pared to studies with piglets or human models.
Furthermore, we previously demonstrated that the use
of the poultry model for Fe bioavailability studies has
numerous applications [12-15], but in general it can be
used to identify foods, food combinations and factors
within diets that can help prevent Fe deficiency anemia.
Therefore, it may be especially useful in the strategy of
“biofortification”. This approach utilizes plant breeding to
select for traits that enhance the nutritional quality of
crops by increasing Fe concentration and or bioavailability
[24] and requires an inexpensive method that can screen
more than the two to ten advanced lines proposed for var-
ietal release.
In biofortification studies, the effect of a biofortified
food (i.e. nutritional benefit) is expected to be preventa-
tive; thus, depending on the duration of the study and as
previously suggested, Fe deficient (not anemic) animals
are preferred [7,24,25]. Anemic animals are not desirable
for biofortification studies because physiological adapta-
tion may mask differences in bioavailable Fe between test
samples [10,11]. Also, the difference in deliverable Fe
between samples may not be enough to reverse the ane-
mia, or require a longer time to show a measurable bene-
fit. Alternatively, Fe-adequate animals may take a long
time to show depletion of Fe, thus less effect would be
shown during a study. Therefore, the initial Fe status
should be established to accommodate possible changes
in Fe status and thus maximize the potential for mea-
surement of physiological effects.
Based on the above, one of the parameters we chose to
use as a physiological marker of Fe status was the
increase in body Fe in the birds as an index of Fe
absorption. To do this, we needed to accurately measure
the accumulation of Fe in the animal over an extended
feeding period. Our rationale was that if we could keep
our birds Fe deficient, then their Fe stores should be
minimal and we could use Hb Fe and tissue Fe levels as a
reasonable index of absorbed Fe. This approach is based
on the concept that storage Fe is almost completely
depleted before Fe deficiency anemia develops [25]. We
monitored the Fe status of the chicks so that they would
be Fe-deficient (and not anemic) at the start of the study;
broiler hatchlings grow rapidly and therefore have very
high Fe requirements, hence, at hatch broiler chicks are
F ed e f i c i e n t[ 1 5 ]a n dw i t h o u tt h ea p p r o p r i a t ed i e tw i l l
develop severe Fe deficiency [11].
In this study, the mean Hb concentrations in both
groups at the start of the feeding period was 91 g/L. This
Hb status may increase or decrease dependent on the
given dietary Fe concentrations and bioavailability. The
Hb concentrations were maintained at this level through-
out the study in the group receiving biofortified beans
(“High Fe” group) but fell in the standard (“Low Fe”)
bean group (Figure 1). This suggested a nutritional bene-
fit from the high Fe nutritionally-enhanced, red-mottled
beans.
In addition to the physiological parameters mentioned
above, we also measured the effect of the experimental
diets on Fe transporters and enzyme expression. It was
previously established that Fe absorption is regulated, in
part, by the intracellular Fe concentrations in the enter-
ocyte [26]. Iron ions (Fe
2+ and Fe
3+) reach the duodenal
brush border membrane then are reduced by DcytB to
Fe
2+ (unless already in the Fe
2+ form), which is then
transported into the enterocyte via DMT-1. Other
mechanisms for Fe entry into enterocytes are possible
and likely but have not been conclusively demonstrated
[27]. Within the cell, Fe is either stored as ferritin or
trafficked to the basolateral membrane and exported
into the circulation. Transport across the basolateral
membrane is accomplished by the coordinated action of
ferroportin, an Fe transporter, and hephaestin, which
oxidizes Fe
2+ to Fe
3+. Iron ions (Fe
3+)t h e nb i n dt o
transferrin for distribution throughout the body via the
plasma circulation [28,29].
In the current study, the duodenal relative mRNA
abundance of DMT-1, DcytB and ferroportin were
higher in the “Low Fe” group vs. the “High Fe” group,
Table 4 Ferritin protein and the iron
1 concentration in the liver tissue in birds given “High Fe” diet (54 ppm Fe) and
“Low Fe” (42 ppm Fe)(values are mean ± SEM, n = 6)
Treatment diet Ferritin μg/g wet weight Iron μg/g wet weight Iron/Ferritin μmol
“High Fe” 425 ± 18
a 48.1 ± 4.2
a 68.5 ± 5.6
a
“Low Fe” 409 ± 12
a 39.5 ± 3.5
a 59.8 ± 5.2
a
1Atomic mass for iron is 55.8 g/mol.
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Page 8 of 10however, the up regulation was not significant (P >
0.05). We previously showed that increased expression
of intestinal Fe related transporters and enzymes indi-
cated on Fe deficiency [12,14,15]. This pattern of
expression was observed in the present study and was
described in Fe-deficient rats and in vitro [30]. It was
also shown that the elevated gene expression for these
transporters and enzymes is due to the dietary Fe defi-
ciency conditions and increases cellular Fe uptake and
export into the circulation [30]. These observations indi-
cate that the Fe uptake mechanisms in the broiler are
responding as expected to dietary Fe [11,14,15]. This
also implies that the biofortified red beans improved the
Fe status of the Fe deficient birds.
Other major parameters for Fe status are liver ferritin
and liver Fe concentrations. Ferritin, as the cellular Fe-
binding protein, represents the Fe status of the tissue
and reflects on the Fe status of the body [20,21,31]. In
the present study, we document quantification of liver
ferritin; studying the ferritin protein in its native state
has allowed us to calculate t h eF eb o u n dt oi t sc o r e
[14,15,20,32]. Our results showed that birds fed the
“High Fe” diet had higher liver ferritin concentrations
(P > 0.05). Although this increase in ferritin concentra-
tion was not significant, it is still indicates on higher Fe
bioavailability in the “High Fe” diet. Also, liver Fe con-
centrations were lower (P > 0.05) in the “Low Fe” diet
g r o u pi nc o m p a r i s o nt o“High Fe” group. These obser-
vations verify the in-vitro model results, indicating that
Fe bioavailability was higher in the “High Fe” bean
based diet relative to the “Low Fe” bean based diet.
In summary, the current study suggests that increasing
Fe concentrations in large-seeded, red-mottled beans by
about 25 μg/g should provide more bioavailable and
therefore absorbable Fe. Also, increased Fe concentra-
tion seems to limit the polyphenolic inhibitory effect on
Fe absorption from colored beans. Hence, use of plant
breeding programs strategies of selection for high Fe
content may have significant nutritional benefits.
Conclusions
Based on the data shown here, we conclude that the
biofortified beans are a promising vehicle for increasing
intakes of bioavailable Fe in human populations where
beans are a dietary staple and that colored beans contain
relatively high levels of bioavailable Fe. An efficacy trial
comparing biofortified and standard red-mottled beans
in human populations is needed to confirm the findings
reported here.
Endnotes
1 Mention of a trademark, proprietary product or ven-
dor does not constitute a guarantee or warranty of the
product by the United states Department of Agriculture
and does not imply its approval to the exclusion of
other products or vendors that may also be suitable.
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